John C. Martin's Insider Trades & SAST Disclosures
John C. Martin's most recent trade in Sarepta Therapeutics Inc was a trade of 5,518 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John C. Martin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics Inc | John C. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 5,518 | 5,518 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | John C. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 2,726 | 7,913 (0%) | 0% | 0 | Common Stock | |
| Kronos Bio Inc | John C. Martin | Director | 14 Oct 2020 | 914,333 | 914,333 | - | - | Common Stock | ||
| Kronos Bio Inc | John C. Martin | Director | 14 Oct 2020 | 866,667 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | John C. Martin | Director | 14 Oct 2020 | 756,971 | 1,671,304 | - | - | Common Stock | ||
| Kronos Bio Inc | John C. Martin | Director | 14 Oct 2020 | 717,509 | 0 | - | - | Series A Preferred Stock | ||
| Kronos Bio Inc | John C. Martin | Director | 14 Oct 2020 | 205,260 | 1,876,564 | - | 16.2 | 3,314,949 | Common Stock | |
| Kronos Bio Inc | John C. Martin | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 14 Oct 2020 | 75,800 | 1,952,364 | - | 19 | 1,440,200 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges